Maze Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MAZE and other ETFs, options, and stocks.About MAZE
Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes the Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process to refer a variant functionalization.
MAZE Key Statistics
Stock Snapshot
The current Maze Therapeutics(MAZE) stock price is $45.30, with a market capitalization of 2.18B. The stock trades at a price-to-earnings (P/E) ratio of -20.62.
On 2026-03-05, Maze Therapeutics(MAZE) stock traded between a low of $44.59 and a high of $46.35. Shares are currently priced at $45.30, which is +1.6% above the low and -2.3% below the high.
The Maze Therapeutics(MAZE)'s current trading volume is 349.7K, compared to an average daily volume of 338.29K.
During the past year, Maze Therapeutics(MAZE) stock moved between $6.71 at its lowest and $49.25 at its peak.
During the past year, Maze Therapeutics(MAZE) stock moved between $6.71 at its lowest and $49.25 at its peak.
Analyst ratings
100%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.